Point72 Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.19M Sell
12,600
-125,300
-91% -$68M 0.01% 1551
2025
Q4
$79.9M Buy
+137,900
New +$78M 0.09% 246
2025
Q1
Sell
-21,900
Closed -$11.4M 2535
2024
Q4
$11.4M Buy
21,900
+12,800
+141% +$7.04M 0.03% 646
2024
Q3
$5.63M Buy
+9,100
New +$5.39M 0.01% 849

Other funds holding TMO

Point72 Asset Management's TMO Position: Q1 2026 in Review

Point72 Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q1 2026, selling an estimated $45.2M and leaving 353,541 shares worth $174M. The position accounts for 0.22% of the portfolio, ranked #68.

Point72 Asset Management first reported a position in TMO in Q2 2014 and has held it in 32 quarters since. The position peaked at $253M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Point72 Asset Management held 353,541 shares of Thermo Fisher Scientific worth $174M as of Q1 2026.
  • Point72 Asset Management sold 83,317 Thermo Fisher Scientific shares in Q1 2026, an estimated $45.2M.
  • Thermo Fisher Scientific made up 0.22% of Point72 Asset Management's portfolio in Q1 2026, its #68 holding.
  • Point72 Asset Management first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 32 quarters since.
  • Point72 Asset Management's Thermo Fisher Scientific position peaked at $253M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.